Effectiveness of sildenafil and U-74389G in a rat model of colitis.
Georgios Antonios Margonis, Nikolaos Christoloukas, Efstathios Antoniou, Nikolaos Arkadopoulos, George Theodoropoulos, George Agrogiannis, Emmanouil Pikoulis, Efstratios S Patsouris, George C Zografos, Apostolos E Papalois
Index: J. Surg. Res. 193(2) , 667-74, (2015)
Full Text: HTML
Abstract
Crohn disease is still incurable. Compounds with anti-inflammatory and/or antioxidative effects are tested in various preclinical models of the disease. Our aim was to investigate the effects of sildenafil and lazaroid U-74389G in an experimental rat model of trinitrobenzenesulfonic acid-induced colitis.Trinitrobenzenesulfonic acid was instilled into the colon of all male Wistar rats except for the rats belonging to the first group. For 6 days, the animals in group 3 were administered daily sildenafil orally, the rats in group 4 were administered daily U-74389G intravenously, and the rats in group 5 were coadministered daily sildenafil orally and intravenous U-74389G. The rats in groups 1 and 2 were not administered any treatment. During the study, the weights were recorded as a marker of clinical condition. The colon damage was evaluated using macroscopic colon mucosal damage index (CMDI), microscopic (Geboes score), and biochemical methods (tissue tumor necrosis factor [TNF]-α and malondialdehyde [MDA]).Sildenafil reduced TNF-α tissue levels and increased body weight. U-74389G reduced TNF-α, the macroscopic index of mucosal damage score (CMDI) and increased body weight. The combined treatment with sildenafil and U-74389G reduced tissue levels of both TNF-α and MDA, lowered CMDI and microscopic Geboes score, and increased body weight.U-74389G demonstrated a significant anti-inflammatory activity related to its ability to reduce colonic TNF-α, CMDI score, and improve weight change. We confirmed that sildenafil has anti-inflammatory capacity by reducing colonic TNF-α and by improving body weight. Finally, the combined treatment showed superior effects by reducing colonic TNF-α, colonic MDA, CMDI score, Geboes score, and by improving weight.Copyright © 2015 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
2015-12-01
[Neuropharmacology 99 , 422-31, (2015)]
2001-11-01
[Hepatology 34(5) , 990-9, (2001)]
1995-07-15
[Circulation 92 , 238, (1995)]
1995-10-01
[J. Am. Soc. Nephrol. 6 , 1300, (1995)]
1995-09-01
[Free Radic. Biol. Med. 19 , 349, (1995)]